Jan van de Winkel to deliver the Utrecht Science Lecture during the opening of Utrecht Science Week 2025
We are thrilled to announce that Prof. Dr. Jan van de Winkel, President & CEO of Genmab, will present the keynote opening Utrecht Science Lecture during the 2025 Utrecht Science Week on September 26. As a pioneering scientist and industry leader in antibody-based therapies, Jan van de Winkel has been at the forefront of groundbreaking advancements in immunotherapy, shaping the future of cancer treatment and beyond.
With more than 30 years of experience in therapeutic antibodies, Jan van de Winkel has played a pivotal role in translating cutting-edge science into life-changing medicines. As a co-founder of Genmab, he has led the company’s journey from an ambitious startup to a global end-to-end biotech powerhouse. In addition to his executive role, he holds a professorship in immunotherapy at Utrecht University, contributing to academic research and fostering the next generation of scientific leaders.
In his lecture, titled “Cracking the Code on Cancer and Other Serious Diseases: The Past, Present, and Future of Immunotherapy”, he will explore how immunotherapy is revolutionizing medicine. From early discoveries to today’s breakthroughs in cancer care, he will offer insights into the evolving role of antibody therapies, the next frontiers in biotechnology, and the power of collaboration and AI in driving innovation.
As Utrecht Science Week celebrates its fifth edition, this keynote lecture will highlight Utrecht’s ambition as the “Heart of Health” and the Utrecht Science Park as a unique life sciences ecosystem for cutting-edge research and medical innovation. Join us to gain a front-row perspective on the future of immunotherapy and how partnerships between academia, industry, and healthcare can accelerate progress for patients worldwide.
You can register here.
Olympic champion Maarten van der Weijden swims one last time, now for the Máxima
Maarten van der Weijden is putting on his swimming suit one last time to raise money for cancer research. From 17 to 22 August, he will swim an incredible 270 kilometers through 22 cities, with the Princess Máxima Center as his final destination. With this special challenge, he is raising money for pioneering research into the immediate and long-term effects of childhood cancer.
New exit for construction traffic at the Utrecht Science Park
Various construction works are taking place in the north-west cluster of Utrecht Science Park. This is the area where the Minnaert Building and the Buys Ballot Building, amongst others, are located. To ensure that construction traffic flows more safely and efficiently through the area, a new exit is being constructed from Sorbonnelaan to Leuvenlaan.
Eliminating cancer with light
Killing tumors with light. Is that something for the distant future? Certainly not! UMC Utrecht and start-up Lumox are now going to test an innovative therapy in a first patient study.
Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals
On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).